InvestorsHub Logo
Followers 737
Posts 76052
Boards Moderated 0
Alias Born 01/01/2012

Re: BAMF31 post# 97883

Tuesday, 06/20/2017 1:05:45 PM

Tuesday, June 20, 2017 1:05:45 PM

Post# of 203913
That is complete BS - I hope your investment strategy isn't based on the nonsense in a press release or 8-K.

Pharmaceutical companies publish their research in peer reviewed Journals from pre-clinical trials and as they progress through each stage of the trials.

How in the hell is releasing the efficacy report going to undermine the IP - that is deflection and defending the OWCP scam.

Take a look at all of the scientific publications that GW Pharmaceuticals release every year.

The problem is too many people invested in OWCP thinking they owned 7 patents - which isn't close to being truthful.

Are you suggesting that that patent applications (which were all rejected) isn't enough protection?

The information from the company is smoke and mirrors - at it's comical best.

"Read the 8-K released on April 4th. "...The Company actively protects its IP and will release the final results, relevant protocols and clinical data after the completion of the full BIO-DATA IP PROTECTION....""

This is so the OWCP scammers can keep dangling the carrots in front of investors.

IG

"Straight Facts Homey!"